RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Laboratorio Reig Jofre Stock

Laboratorio Reig Jofre P/E 2024

Laboratorio Reig Jofre P/E

19.08

Ticker

RJF.MC

ISIN

ES0165359029

WKN

A140EW

As of Nov 18, 2024, Laboratorio Reig Jofre's P/E ratio was 19.08, a -8.88% change from the 20.94 P/E ratio recorded in the previous year.

The Laboratorio Reig Jofre P/E history

Laboratorio Reig Jofre Aktienanalyse

What does Laboratorio Reig Jofre do?

Laboratorio Reig Jofre SA is a leading company in the pharmaceutical industry, specializing in the development, manufacturing, and marketing of drugs. The company was founded in 1929 by the Reig Jofre brothers in Barcelona, Spain. It has since become an international company with a wide portfolio of products and a high level of innovation and quality. The business model of Laboratorio Reig Jofre SA is based on implementing research and innovation in the field of pharmacy. The company has its own R&D department, which collaborates closely with major scientific organizations and universities in Spain to understand and apply the latest developments and innovations in the industry. Laboratorio Reig Jofre SA has three main divisions - human pharmaceuticals, veterinary medicine, and chemical products used in various industries such as cosmetics and food. The human pharmaceutical division includes a variety of products, including prescription drugs, over-the-counter products, and generics, with a focus on therapy areas such as oncology, antibiotics, gynecology, and central nervous system disorders. The veterinary medicine division provides a wide range of vaccines and medications for animal health. The third division of chemical products includes various products such as emulsifiers, preservatives, and natural dyes that can be used in different industries. Some of the most well-known products of Laboratorio Reig Jofre SA include the antibiotic Nitrofurantoin, the analgesic Algiasdin, the hormonal preparation Ovusitol, and the vaccine against Bluetongue in animals. The company has also carried out several successful acquisitions to expand its portfolio and strengthen its international presence. The acquisition of Derivados Quimicos SA (Derma SA) introduced Laboratorio Reig Jofre SA to the skincare sector and strengthened its presence in Latin America. The acquisition of Bioiberica SA introduced the company to the field of bioactive molecules and chondroprotectants. Laboratorio Reig Jofre SA is a company that places quality and innovation at the heart of its activities. The company has a strong corporate culture based on respect, transparency, integrity, and commitment. It has also shown a strong commitment to sustainability and social responsibility, with initiatives such as supporting projects to improve the health of women and children in Africa and implementing environmentally friendly practices in production. Overall, Laboratorio Reig Jofre SA is a leading company in the pharmaceutical industry, capable of offering a wide range of products through research, innovation, and quality. With its diverse portfolio of products and its commitment to sustainability and social responsibility, the company is well-equipped to continue playing a leading role in the industry in the future. Laboratorio Reig Jofre ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Laboratorio Reig Jofre's P/E Ratio

The Price to Earnings (P/E) Ratio of Laboratorio Reig Jofre is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Laboratorio Reig Jofre's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Laboratorio Reig Jofre is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Laboratorio Reig Jofre’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Laboratorio Reig Jofre stock

What is the price-to-earnings ratio of Laboratorio Reig Jofre?

The price-earnings ratio of Laboratorio Reig Jofre is currently 19.08.

How has the price-earnings ratio of Laboratorio Reig Jofre changed compared to last year?

The price-to-earnings ratio of Laboratorio Reig Jofre has increased by -8.88% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Laboratorio Reig Jofre high compared to other companies?

Yes, the price-to-earnings ratio of Laboratorio Reig Jofre is high compared to other companies.

How does an increase in the price-earnings ratio of Laboratorio Reig Jofre affect the company?

An increase in the price-earnings ratio of Laboratorio Reig Jofre would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Laboratorio Reig Jofre affect the company?

A decrease in the price-earnings ratio of Laboratorio Reig Jofre would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Laboratorio Reig Jofre?

Some factors that influence the price-earnings ratio of Laboratorio Reig Jofre are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Laboratorio Reig Jofre pay?

Over the past 12 months, Laboratorio Reig Jofre paid a dividend of 0.08 EUR . This corresponds to a dividend yield of about 2.76 %. For the coming 12 months, Laboratorio Reig Jofre is expected to pay a dividend of 0.06 EUR.

What is the dividend yield of Laboratorio Reig Jofre?

The current dividend yield of Laboratorio Reig Jofre is 2.76 %.

When does Laboratorio Reig Jofre pay dividends?

Laboratorio Reig Jofre pays a quarterly dividend. This is distributed in the months of July, August, June, June.

How secure is the dividend of Laboratorio Reig Jofre?

Laboratorio Reig Jofre paid dividends every year for the past 10 years.

What is the dividend of Laboratorio Reig Jofre?

For the upcoming 12 months, dividends amounting to 0.06 EUR are expected. This corresponds to a dividend yield of 2.18 %.

In which sector is Laboratorio Reig Jofre located?

Laboratorio Reig Jofre is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratorio Reig Jofre kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratorio Reig Jofre from 6/21/2024 amounting to 0.04 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Laboratorio Reig Jofre pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of Laboratorio Reig Jofre in the year 2023?

In the year 2023, Laboratorio Reig Jofre distributed 0.996 EUR as dividends.

In which currency does Laboratorio Reig Jofre pay out the dividend?

The dividends of Laboratorio Reig Jofre are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Laboratorio Reig Jofre

Our stock analysis for Laboratorio Reig Jofre Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratorio Reig Jofre Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.